{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:28:24Z","timestamp":1749634104866},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":7068,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1023\/a:1008354429921","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:41:38Z","timestamp":1040568098000},"page":"1195-1196","source":"Crossref","is-referenced-by-count":18,"title":["Hepatocellular carcinoma after long-term tamoxifen therapy"],"prefix":"10.1016","volume":"11","author":[{"given":"D.F.","family":"Moffat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.A.","family":"Oien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Habeshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.R.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008354429921_bb0005","first-page":"3461","article-title":"Adjuvant chemotherapy for breast cancer","volume":"24","year":"1985","journal-title":"JAMA"},{"key":"10.1023\/A:1008354429921_bb0010","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0140-6736(92)93162-G","article-title":"The case for clinical trials of tamoxifen for the prevention of early breast cancer","volume":"340","author":"Powles","year":"1992","journal-title":"Lancet"},{"key":"10.1023\/A:1008354429921_bb0015","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0140-6736(92)93161-F","article-title":"Tamoxifen: Disease prevention or disease substitution?","volume":"340","author":"Fugh-Berman","year":"1992","journal-title":"Lancet"},{"key":"10.1023\/A:1008354429921_bb0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00666064","article-title":"The incidence of hepatocellular carcinoma in US white women with breast cancer after the introduction of tamoxifen in 1977","volume":"30","author":"Muhlemann","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"10.1023\/A:1008354429921_bb0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","article-title":"Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers","volume":"8630","author":"Fornander","year":"1989","journal-title":"Lancet"},{"key":"10.1023\/A:1008354429921_bb0030","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/bmj.292.6532.1357","article-title":"Cancer of the liver and oral contraceptives","volume":"292","author":"Forman","year":"1986","journal-title":"BMJ"},{"key":"10.1023\/A:1008354429921_bb0035","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/jnci\/83.20.1450","article-title":"Potential role of tamoxifen in prevention of breast cancer","volume":"83","author":"Nayfleld","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008354429921_bb0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7258(84)90043-3","article-title":"The pharmacology and clinical uses of tamoxifen","volume":"25","author":"Furr","year":"1984","journal-title":"Pharmacol Ther"},{"key":"10.1023\/A:1008354429921_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0091-7435(91)90004-N","article-title":"Synthetic oestrogens and tamoxifen as promoters of hepatocarcinogenesis","volume":"20","author":"Jager","year":"1991","journal-title":"Prevent Med"},{"key":"10.1023\/A:1008354429921_bb0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/carcin\/14.2.315","article-title":"The triphenlyethylene drug tamoxifen is a strong liver carcinogen in the rat","volume":"14","author":"Williams","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1023\/A:1008354429921_bb0055","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/carcin\/18.11.2209","article-title":"Investigation of the formation and accumulation of liver DNA adducts in mice chronically exposed to tamoxifen","volume":"18","author":"Martin","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1023\/A:1008354429921_bb0060","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/carcin\/16.7.1651","article-title":"32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifen","volume":"16","author":"Martin","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1023\/A:1008354429921_bb0065","first-page":"105","article-title":"Relevance of rat liver tumours to human hepatic and endometrial cancer","volume":"24","author":"Guzelian","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008354429921_bb0070","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1023\/A:1008269025294","article-title":"Tamoxifen in liver disease: Potential exacerbation of hepatic dysfunction","volume":"8","author":"Floren","year":"1998","journal-title":"Ann Oncol"},{"issue":"353","key":"10.1023\/A:1008354429921_bb0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(05)74872-8","article-title":"Cirrhosis with steatohepatitis after adjuvant tamoxifen","volume":"9146","author":"Oien","year":"1999","journal-title":"Lancet"},{"key":"10.1023\/A:1008354429921_bb0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1008285123736","article-title":"Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials","volume":"8","author":"Simonetti","year":"1997","journal-title":"Ann Oncol"},{"issue":"352","key":"10.1023\/A:1008354429921_bb0085","first-page":"17","article-title":"CLIP Group","volume":"9121","year":"1998","journal-title":"Lancet"},{"key":"10.1023\/A:1008354429921_bb0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0936-6555(05)80844-1","article-title":"Primary hepatocellular carcinoma in a patient with breast cancer","volume":"3","author":"Johnstone","year":"1991","journal-title":"Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420312084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420312084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/9\/1195\/19478647\/11-9-1195.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:37:15Z","timestamp":1582184235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420312084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0923753420312084"],"URL":"https:\/\/doi.org\/10.1023\/a:1008354429921","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}